| Gregory L Barth, MD | |
|
2211 Park Ave, Minneapolis, MN 55404-3711 | |
| (612) 871-1144 | |
| (612) 871-2012 |
| Full Name | Gregory L Barth |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 41 Years |
| Location | 2211 Park Ave, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184625659 | NPI | - | NPPES |
| 104241 | Other | MN | UCARE |
| 88308 | Other | MN | AMERICA'S PPO |
| 10-28847 | Other | MN | MEDICA |
| 1000374 | Other | MN | PREFERRED ONE |
| 2M769BA | Other | MN | BLUE CROSS |
| 10-00010 | Other | MN | MEDICA PRIMARY - GROUP # |
| 276365600 | Medicaid | MN | |
| 31969900 | Other | WI | EDS - WISCONSIN MEDICAID |
| 0911388 | Other | IA | IOWA MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 36229 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose And Throat Specialty Care Of Minnesota Pa | 3274524020 | 38 |
News Archive
Biomedical and health IT solution developer Quertle LLC today released Quetzal Search and Communication biomedical search engine. Built on Quertle's Quantum Logic Linguistic technology, Quetzal is specifically optimized for biomedical, life science and healthcare professionals.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.
In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.
› Verified 7 days ago
| Entity Name | Ear Nose & Throat Specialty Care Of Minnesota Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336175744 PECOS PAC ID: 3274524020 Enrollment ID: O20051116000590 |
News Archive
Biomedical and health IT solution developer Quertle LLC today released Quetzal Search and Communication biomedical search engine. Built on Quertle's Quantum Logic Linguistic technology, Quetzal is specifically optimized for biomedical, life science and healthcare professionals.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.
In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory L Barth, MD 2211 Park Ave, Minneapolis, MN 55404-3711 Ph: (612) 871-1144 | Gregory L Barth, MD 2211 Park Ave, Minneapolis, MN 55404-3711 Ph: (612) 871-1144 |
News Archive
Biomedical and health IT solution developer Quertle LLC today released Quetzal Search and Communication biomedical search engine. Built on Quertle's Quantum Logic Linguistic technology, Quetzal is specifically optimized for biomedical, life science and healthcare professionals.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.
In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.
› Verified 7 days ago
Jeffrey C. Manlove, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Richard M. Levinson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Robert H Maisel, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, P7, Minneapolis, MN 55415 Phone: 612-873-2424 | |
Sivakumar Chinnadurai, MD, MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave Ste 450, Minneapolis, MN 55404 Phone: 615-813-6000 | |
Samir Suresh Khariwala, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 516 Delaware St Se, Clinic 8a, Minneapolis, MN 55455 Phone: 612-625-7400 | |
Tina Chung-ting Huang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, University Of Minnesota Physicians, Minneapolis, MN 55455 Phone: 612-626-5900 | |
Carrie E Flanagan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 420 Delaware St Se, Mmc 293, Minneapolis, MN 55455 Phone: 612-625-7634 |